Online Exclusives

Online Exclusives

Bluebird Bio Wins European Approval for First Beta Thalassemia Gene Therapy

Bluebird Bio’s one-time gene therapy, Zynteglo, has been cleared by EU regulators for the treatment of beta thalassemia in patients aged 12 and older....

FDA Launches Call Center for Compassionate Use Requests

The U.S. Food and Drug Administration (FDA) has launched a call center to field doctors’ requests for access to experimental cancer drugs for individual...

Prices Soar for U.S.’ Most Popular Drugs

A new study from JAMA Network Open indicated that prices for all but one of the best-selling brand name drugs in the U.S. increased...

India Sees Decline in Cases of Severe Anemia

India is home to one-quarter of patients with severe anemia, but a new report from the country’s Health Management Information System found that incidence...

Trump Administration Outlines New Drug Price Transparency Plans

As health-care costs emerges as a crucial issue in the 2020 presidential election, President Donald Trump is preparing to issue an executive order aimed...

Disparities in Time to Treatment Erased in the Affordable Care Act Era

In states that opted to expand Medicaid under the Affordable Care Act (ACA), the time to receiving cancer treatment was nearly identical among white...

FDA Recalls Three Hematology Analyzers

The U.S. Food and Drug Administration (FDA) has issued a Class I recall of three hematology analyzers – Beckman Coulter DxH 800, DxH 600,...

New Senate Health Package Bans “Spread Pricing” Tactics

A highly anticipated package of health care legislation from Sens. Lamar Alexander (R-TN) and Patty Murray (D-WA) that was expected to focus on surprise...

Did the Pharmaceutical Industry Influence WHO’s Pain Treatment Guidelines?

A Congressional report alleges that the World Health Organization’s (WHO’s) treatment guidelines for pain were directly influenced by opioid manufacturer Purdue Pharma. The report, stemming...

CDC: Cancer Death Rates Decline, Yet Heart Disease Deaths Rise

Rates of death from cancer in the U.S. have continued to decline, but deaths due to heart disease are on the rise, according to...
Advertisement

Current Issue

June 2019, Volume 5, Issue 7

This issue features a debate about new treatment options for beta-thalassemia, a look at what’s driving skyrocketing drug prices in myeloma, and more.